- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 08.09. | Quoin in line for second priority review voucher if rare paediatric drug approved | ||
| 08.09. | UK on track to reverse years of pharma decline, ABPI report finds | ||
| 08.09. | LSTM opens $23m robotic AI lab for infection research | ||
| 08.09. | Novartis India acquires Pfizer brands for $132m | ||
| 07.09. | Mosquitos capable of transmitting dengue found breeding in UK for first time | ||
| 07.09. | Aptar Pharma to support Aceso's inhaled cystic fibrosis candidate's advance | ||
| 07.09. | EU pharma industry pushes for expansion of barcodes on medicines | ||
| 07.09. | AtomVie opens $160m radiopharmaceutical manufacturing facility in Ontario | ||
| 07.09. | FDA approves AstraZeneca's Etcamah combo for advanced breast cancer | ||
| 04.09. | Pineapples and green tea: FDA turns to public for new approaches to botanical drugs | ||
| 04.09. | Ionis nets Zanvastro US approval in first for Alexander disease | ||
| 04.09. | FDA rallies HRT manufacturers amid US-wide estradiol patch shortage | ||
| 04.09. | Superluminal Medicines secures $60m to advance rare obesity therapy | ||
| 04.09. | Médunik and Biocodex sign exclusive agreement for Diacomit in Canada | ||
| 03.09. | GSK licenses HUTCHMED's solid tumour conjugate in up to $1.3bn deal | ||
| 03.09. | Typewriter raises $56m Series A to progress non-viral gene therapy platform | ||
| 03.09. | Biocytogen and Qilu Pharmaceutical sign agreement for VHH antibody molecule | ||
| 03.09. | Novartis signs deal with Alteogen for drug delivery | ||
| 02.09. | FDA cracks down on online black market for weight loss peptides | ||
| 02.09. | Roche licenses Simcere's B-cell-targeting tri-specific for $1.53bn | ||
| 02.09. | Ono Pharmaceutical joins forces with Aitia for drug discovery in neurology | ||
| 02.09. | Takeda and Weave Bio collaborate on AI-driven automation in drug development | ||
| 01.09. | Trump lines up MFN deals with nine mid-size pharmas on drug pricing push | ||
| 01.09. | Eli Lilly continues near-monthly M&A presence with $2.9bn Merida deal | ||
| 01.09. | PharmaEssentia's Besremi receives FDA approval for ET |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.